| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $788.2M | -3.3% | +18.7% |
| Cost of Revenue | $417.5M | -5.3% | +13.4% |
| Gross Profit | $370.7M | -0.9% | +25.3% |
| R&D Expense | $51.8M | +1.9% | +17.1% |
| SG&A Expense | $28.1M | -7.2% | +13.4% |
| Operating Income | $290.8M | -0.7% | +28.2% |
| Pre-tax Income | $290.2M | -0.4% | +31.0% |
| Income Tax | $56.2M | -2.5% | +37.2% |
| Net Income | $233.9M | +0.1% | +29.6% |
| EPS (Basic) | $3.87 | +0.3% | +29.9% |
| EPS (Diluted) | $3.86 | +0.0% | +29.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $368.7M | +21.7% | +144.2% |
| Accounts Receivable | $245.8M | +14.7% | +10.6% |
| Inventory | $654.0M | -3.1% | +10.8% |
| Current Assets | $1.40B | +8.6% | +29.7% |
| Total Assets | $1.72B | +6.7% | +32.1% |
| Current Liabilities | $394.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $630.1M | — | — |
| Capital Expenditures | $14.3M | — | — |
| Investing Cash Flow | -$14.3M | — | — |
| Financing Cash Flow | -$396.9M | — | — |
| Free Cash Flow | $615.8M | — | — |
| -49.4% |
| Total Liabilities | $513.3M | -13.4% | -40.5% |
| Stockholders' Equity | $1.20B | +18.4% | +175.7% |